piretanide has been researched along with Cirrhosis, Liver in 5 studies
piretanide: potent inhibitor of chloride transport; structure
Excerpt | Relevance | Reference |
---|---|---|
"The pharmacokinetics of piretanide, a new loop diuretic, were studied in seven patients with severe liver disease before and after resolution of ascites." | 9.05 | The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients. ( Bouchier, IA; Shepherd, AN, 1985) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 7.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
"The pharmacokinetics of piretanide, a new loop diuretic, were studied in seven patients with severe liver disease before and after resolution of ascites." | 5.05 | The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients. ( Bouchier, IA; Shepherd, AN, 1985) |
"The binding of three loop diuretics, piretanide, bumetanide and furosemide, to serum proteins from patients with liver cirrhosis or fulminant hepatitis was investigated using equilibrium dialysis." | 3.66 | Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease. ( Fujii, S; Fujiwara, K; Goto, S; Miyamoto, A; Nakayama, T; Yamada, H; Yoshitomi, H, 1981) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 3.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyer, TD | 1 |
Warnock, DG | 1 |
Scarpioni, L | 1 |
Crippa, G | 1 |
Zanazzi, MA | 1 |
Goto, S | 1 |
Yoshitomi, H | 1 |
Miyamoto, A | 1 |
Yamada, H | 1 |
Fujii, S | 1 |
Nakayama, T | 1 |
Fujiwara, K | 1 |
Arroyo, V | 1 |
Bosch, J | 1 |
Casamitjana, R | 1 |
Cabrera, J | 1 |
Rivera, F | 1 |
Rodés, J | 1 |
Shepherd, AN | 1 |
Bouchier, IA | 1 |
2 trials available for piretanide and Cirrhosis, Liver
Article | Year |
---|---|
Use of diuretics in the treatment of cirrhotic ascites.
Topics: Ascites; Bumetanide; Diuresis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Humans; Kidn | 1983 |
The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients.
Topics: Absorption; Adult; Aged; Ascites; Biological Availability; Diuretics; Female; Humans; Kinetics; Live | 1985 |
3 other studies available for piretanide and Cirrhosis, Liver
Article | Year |
---|---|
[Piretanide in the therapy of water-sodium retention in hepatic cirrhosis].
Topics: Adult; Aged; Anuria; Body Water; Diuretics; Humans; Liver Cirrhosis; Male; Middle Aged; Potassium; S | 1982 |
Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
Topics: Adult; Bilirubin; Blood Proteins; Bumetanide; Diuretics; Female; Furosemide; Hepatitis; Humans; Live | 1981 |
Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Humans; Liver Cirrh | 1980 |